← Open Payments lookup

MEGAN GRANCHELLI: Open Payments

NPI 1962904607 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$205 in 10 payments from 9 companies in 2025. Trend: 2023 $317 · 2024 $662 · 2025 $205

Food & beverage: $205
CompanyPaymentsAmount
GlaxoSmithKline, LLC.2$34
Insulet Corporation1$27
Edwards Lifesciences Corporation1$27
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$24
Exact Sciences Corporation1$22
Novo Nordisk Inc1$20
Amgen Inc.1$18
Lilly USA, LLC1$17
E.R. Squibb & Sons, L.L.C.1$16

Products named: TRELEGY ELLIPTA, Omnipod, XIFAXAN, The Cologuard Plus Collection Kit, Ozempic, EVENITY, MOUNJARO, CAMZYOS.

Industry payments across NY — which companies pay providers there.